BXP

Investorcompany

Member since October 2024

$4B

Volume

$3B

Sold

$2B

Financed

$42M

Leased

Closed

7M sf

Area

AI SummaryBeta

BXP is a prominent investor company with a volume of $4B, focused primarily on office assets across 7M sf. Recent transactions include a $66.8M sale to Vieron Capital and an expansion lease of 23,000 sf by Rogo Technologies.

AI-generated from Traded deal data. May contain errors.

No bio available yet

This broker hasn't added a bio to their profile yet. Check back later for more details about their background and expertise.

Top Deals

FINANCED

Share this deal

Open in a new tab

BXP Secures $1.2 Billion Construction Loan For 343 Madison Avenue Office Tower In Midtown Manhattan

New York | Office | PPSF: $1290

07/29/2026

SOLD

Share this deal

Open in a new tab

Norges Bank Investment Management Acquires Life Sciences Properties In Cambridge For $746.4M

Massachusetts | Life Sciences | PPSF: $460

11/15/2023

SOLD

Share this deal

Open in a new tab

BXP Acquires Life Science Asset In Cambridge For $592M

Massachusetts | Other | PPSF: $2184

09/20/2022

FINANCED

Share this deal

Open in a new tab

BXP And Delaware North Secure $465 Million Refinancing Loan For The Hub On Causeway In Boston

Massachusetts | Mixed-use | PPSF: $310

09/29/2025

SOLD

Share this deal

Open in a new tab

The Bernstein Companies Acquires 50% Stake In Office Tower At 7750 Wisconsin Avenue For $430M

Maryland | Office | PPSF: $585

04/21/2026

Focus

Life Sciences

Sale

Markets

FAQs

BXP has financed 4 deals.

BXP's most recent deal was on November 15, 2023.

BXP's largest deals include a sale of $746,400,000.00 for 290 Binney Street, and a lease covering 7,000 sqft for 360 Park Avenue South New York, New York 10010, USA.